DT
HealthMore in Health→
Study links tumor splicing burden to treatment response in metastatic renal cell carcinoma
Key Takeaways
- Researchers reported a significant correlation between splicing burden and treatment response.
- The study focuses on metastatic renal cell carcinoma.
- The result points to a possible new biomarker direction in precision oncology.
DE
DT Editorial Team··via medicalxpress.com